CSIMarket
 

Revolution Medicines Inc   (RVMD)
Other Ticker:  
 

Revolution Medicines Inc 's

Competitiveness


 

RVMD Sales vs. its Competitors Q3 2023







Revenue Growth Comparisons




Net Income Comparison




<<  RVMD Stock Performance Comparisons



*Market share is calculated based on total revenue.

  News about Revolution Medicines Inc Contracts

Revolution Medicines Unveils Groundbreaking RAS Inhibitor with Unprecedented Anti-Tumor Activity in Pancreatic Cancer Models

Revolution Medicines Announces Groundbreaking Discovery and Preclinical Profile of New Class of RAS(ON) Multi-Selective Inhibitors with Unprecedented Anti-Tumor Activity in RAS-Mutant Pancreatic Cancer ModelsRevolution Medicines, a leading biotechnology company focused on developing innovative cancer treatments, has recently made significant progress in the field of oncology. In a press release issued today, the company announced the publication of two original papers in the prestigious scientific journal Nature, showcasing the discovery and translational implications of their latest breakthrough compound, RMC-7977.RMC-7977 is a RAS(ON) multi-selective tri-complex inhibitor, specifically designed to block th...





Who are Revolution Medicines Inc 's Competitors?





Help

About us

Advertise

CSIMarket Company, Sector, Industry, Market Analysis, Stock Quotes, Earnings, Economy, News and Research. 
   Copyright © 2024 CSIMarket, Inc. All rights reserved. This site uses cookies to make your browsing experince better. By using this site, you agree to the Terms of Service and Privacy Policy - UPDATED (Read about our Privacy Policy)

Intraday data delayed per exchange requirements. All quotes are in local exchange time. Intraday data delayed 15 minutes for Nasdaq, and other exchanges. Fundamental and financial data for Stocks, Sector, Industry, and Economic Indicators provided by CSIMarket.com